Loading…

Non–heparan sulfate‐binding interactions of endostatin/collagen XVIII in murine development

Knobloch syndrome is characterized by a congenital generalized eye disease and cranial defect. Pathogenic mutations preferentially lead to a deletion or functional alteration of collagen XVIII's most C‐terminal endostatin domain. Endostatin can be released from collagen XVIII and is a potent in...

Full description

Saved in:
Bibliographic Details
Published in:Developmental dynamics 2005-02, Vol.232 (2), p.399-407
Main Authors: Rychkova, Natalia, Stahl, Sonja, Gaetzner, Sabine, Felbor, Ute
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3632-84390126bd584bf454a3572503f14cc8899eb72e25ce696509a6aa15205fdee43
cites cdi_FETCH-LOGICAL-c3632-84390126bd584bf454a3572503f14cc8899eb72e25ce696509a6aa15205fdee43
container_end_page 407
container_issue 2
container_start_page 399
container_title Developmental dynamics
container_volume 232
creator Rychkova, Natalia
Stahl, Sonja
Gaetzner, Sabine
Felbor, Ute
description Knobloch syndrome is characterized by a congenital generalized eye disease and cranial defect. Pathogenic mutations preferentially lead to a deletion or functional alteration of collagen XVIII's most C‐terminal endostatin domain. Endostatin can be released from collagen XVIII and is a potent inhibitor of angiogenesis and tumor growth. We show differential expression of binding partners for endostatin, vascular endothelial growth factor (VEGF), and the collagen XV endostatin homologue in murine embryonal development using a set of alkaline phosphatase fusion proteins. Consistent with the human phenotype, vascular mesenchyme in the developing eye was identified as endostatin's primary target. While endostatin predominantly bound to blood vessels, the VEGF164 affinity probe labeled nonvascular tissues such as forebrain, hindbrain, the optic nerve, and the surface ectoderm of the future cornea. Strikingly increased staining specificity was observed with a non–heparin/heparan sulfate‐binding endostatin probe. In contrast, elimination of the heparan sulfate binding site from VEGF led to complete loss of binding. The collagen XV endostatin homologue showed a highly restricted binding pattern. Oligomerization with endogenous endostatin was ruled out by use of collagen XVIII knockout mice. Our data provide strong evidence that collagen XVIII's C‐terminal endostatin domain harbors a prominent tissue‐binding site and that binding can occur in the absence of heparan sulfates in situ. Developmental Dynamics 232:399–407, 2005. © 2004 Wiley‐Liss, Inc.
doi_str_mv 10.1002/dvdy.20222
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67366577</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67366577</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3632-84390126bd584bf454a3572503f14cc8899eb72e25ce696509a6aa15205fdee43</originalsourceid><addsrcrecordid>eNp9kMtKxDAUhoMojreNDyBduRDqJGlz6VJmvBRENzroKqTtqUbapDatMjsfQfANfRI7dsCdq3MWHx8_H0KHBJ8SjOm0eCuWpxRTSjfQDsGJCDERYnP1MxnKSMoJ2vX-BWMseUy20YQwTmLB6Q5SN85-f3w9Q6NbbQPfV6Xu4PvjMzO2MPYpMLaDVuedcdYHrgzAFs53ujN2mruq0k9gg4dFmqYDGdR9aywEBbxB5ZoabLePtkpdeThY3z10f3F-N7sKr28v09nZdZhHPKKhjKMEE8qzgsk4K2MW64gJynBUkjjPpUwSyAQFynLgCWc40VxrwihmZQEQR3voePQ2rXvtwXeqNj6HYaAF13vFRcQ5E2IAT0Ywb533LZSqaU2t26UiWK1yqlVO9ZtzgI_W1j6rofhD1_0GgIzAu6lg-Y9KzRfzx1H6AyJXgmE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67366577</pqid></control><display><type>article</type><title>Non–heparan sulfate‐binding interactions of endostatin/collagen XVIII in murine development</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Rychkova, Natalia ; Stahl, Sonja ; Gaetzner, Sabine ; Felbor, Ute</creator><creatorcontrib>Rychkova, Natalia ; Stahl, Sonja ; Gaetzner, Sabine ; Felbor, Ute</creatorcontrib><description>Knobloch syndrome is characterized by a congenital generalized eye disease and cranial defect. Pathogenic mutations preferentially lead to a deletion or functional alteration of collagen XVIII's most C‐terminal endostatin domain. Endostatin can be released from collagen XVIII and is a potent inhibitor of angiogenesis and tumor growth. We show differential expression of binding partners for endostatin, vascular endothelial growth factor (VEGF), and the collagen XV endostatin homologue in murine embryonal development using a set of alkaline phosphatase fusion proteins. Consistent with the human phenotype, vascular mesenchyme in the developing eye was identified as endostatin's primary target. While endostatin predominantly bound to blood vessels, the VEGF164 affinity probe labeled nonvascular tissues such as forebrain, hindbrain, the optic nerve, and the surface ectoderm of the future cornea. Strikingly increased staining specificity was observed with a non–heparin/heparan sulfate‐binding endostatin probe. In contrast, elimination of the heparan sulfate binding site from VEGF led to complete loss of binding. The collagen XV endostatin homologue showed a highly restricted binding pattern. Oligomerization with endogenous endostatin was ruled out by use of collagen XVIII knockout mice. Our data provide strong evidence that collagen XVIII's C‐terminal endostatin domain harbors a prominent tissue‐binding site and that binding can occur in the absence of heparan sulfates in situ. Developmental Dynamics 232:399–407, 2005. © 2004 Wiley‐Liss, Inc.</description><identifier>ISSN: 1058-8388</identifier><identifier>EISSN: 1097-0177</identifier><identifier>DOI: 10.1002/dvdy.20222</identifier><identifier>PMID: 15614762</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Alkaline Phosphatase - metabolism ; Animals ; Binding Sites ; Blotting, Western ; Brain - embryology ; Brain - metabolism ; brain and eye development ; Collagen - chemistry ; Collagen Type XVIII - metabolism ; collagen XVIII ; Cornea - embryology ; Electrophoresis, Polyacrylamide Gel ; endostatin ; Endostatins - metabolism ; Eye - embryology ; Gene Expression Regulation, Developmental ; Genetic Vectors ; heparan sulfate ; Heparitin Sulfate - chemistry ; Heparitin Sulfate - metabolism ; Humans ; In Situ Hybridization ; Knobloch syndrome ; Mice ; Mice, Knockout ; Phenotype ; Protein Binding ; Protein Structure, Tertiary ; Recombinant Fusion Proteins - chemistry ; Recombinant Fusion Proteins - metabolism ; Time Factors ; vascular endothelial growth factor ; Vascular Endothelial Growth Factor A - metabolism</subject><ispartof>Developmental dynamics, 2005-02, Vol.232 (2), p.399-407</ispartof><rights>Copyright © 2004 Wiley‐Liss, Inc.</rights><rights>Copyright 2004 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3632-84390126bd584bf454a3572503f14cc8899eb72e25ce696509a6aa15205fdee43</citedby><cites>FETCH-LOGICAL-c3632-84390126bd584bf454a3572503f14cc8899eb72e25ce696509a6aa15205fdee43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15614762$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rychkova, Natalia</creatorcontrib><creatorcontrib>Stahl, Sonja</creatorcontrib><creatorcontrib>Gaetzner, Sabine</creatorcontrib><creatorcontrib>Felbor, Ute</creatorcontrib><title>Non–heparan sulfate‐binding interactions of endostatin/collagen XVIII in murine development</title><title>Developmental dynamics</title><addtitle>Dev Dyn</addtitle><description>Knobloch syndrome is characterized by a congenital generalized eye disease and cranial defect. Pathogenic mutations preferentially lead to a deletion or functional alteration of collagen XVIII's most C‐terminal endostatin domain. Endostatin can be released from collagen XVIII and is a potent inhibitor of angiogenesis and tumor growth. We show differential expression of binding partners for endostatin, vascular endothelial growth factor (VEGF), and the collagen XV endostatin homologue in murine embryonal development using a set of alkaline phosphatase fusion proteins. Consistent with the human phenotype, vascular mesenchyme in the developing eye was identified as endostatin's primary target. While endostatin predominantly bound to blood vessels, the VEGF164 affinity probe labeled nonvascular tissues such as forebrain, hindbrain, the optic nerve, and the surface ectoderm of the future cornea. Strikingly increased staining specificity was observed with a non–heparin/heparan sulfate‐binding endostatin probe. In contrast, elimination of the heparan sulfate binding site from VEGF led to complete loss of binding. The collagen XV endostatin homologue showed a highly restricted binding pattern. Oligomerization with endogenous endostatin was ruled out by use of collagen XVIII knockout mice. Our data provide strong evidence that collagen XVIII's C‐terminal endostatin domain harbors a prominent tissue‐binding site and that binding can occur in the absence of heparan sulfates in situ. Developmental Dynamics 232:399–407, 2005. © 2004 Wiley‐Liss, Inc.</description><subject>Alkaline Phosphatase - metabolism</subject><subject>Animals</subject><subject>Binding Sites</subject><subject>Blotting, Western</subject><subject>Brain - embryology</subject><subject>Brain - metabolism</subject><subject>brain and eye development</subject><subject>Collagen - chemistry</subject><subject>Collagen Type XVIII - metabolism</subject><subject>collagen XVIII</subject><subject>Cornea - embryology</subject><subject>Electrophoresis, Polyacrylamide Gel</subject><subject>endostatin</subject><subject>Endostatins - metabolism</subject><subject>Eye - embryology</subject><subject>Gene Expression Regulation, Developmental</subject><subject>Genetic Vectors</subject><subject>heparan sulfate</subject><subject>Heparitin Sulfate - chemistry</subject><subject>Heparitin Sulfate - metabolism</subject><subject>Humans</subject><subject>In Situ Hybridization</subject><subject>Knobloch syndrome</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Phenotype</subject><subject>Protein Binding</subject><subject>Protein Structure, Tertiary</subject><subject>Recombinant Fusion Proteins - chemistry</subject><subject>Recombinant Fusion Proteins - metabolism</subject><subject>Time Factors</subject><subject>vascular endothelial growth factor</subject><subject>Vascular Endothelial Growth Factor A - metabolism</subject><issn>1058-8388</issn><issn>1097-0177</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNp9kMtKxDAUhoMojreNDyBduRDqJGlz6VJmvBRENzroKqTtqUbapDatMjsfQfANfRI7dsCdq3MWHx8_H0KHBJ8SjOm0eCuWpxRTSjfQDsGJCDERYnP1MxnKSMoJ2vX-BWMseUy20YQwTmLB6Q5SN85-f3w9Q6NbbQPfV6Xu4PvjMzO2MPYpMLaDVuedcdYHrgzAFs53ujN2mruq0k9gg4dFmqYDGdR9aywEBbxB5ZoabLePtkpdeThY3z10f3F-N7sKr28v09nZdZhHPKKhjKMEE8qzgsk4K2MW64gJynBUkjjPpUwSyAQFynLgCWc40VxrwihmZQEQR3voePQ2rXvtwXeqNj6HYaAF13vFRcQ5E2IAT0Ywb533LZSqaU2t26UiWK1yqlVO9ZtzgI_W1j6rofhD1_0GgIzAu6lg-Y9KzRfzx1H6AyJXgmE</recordid><startdate>200502</startdate><enddate>200502</enddate><creator>Rychkova, Natalia</creator><creator>Stahl, Sonja</creator><creator>Gaetzner, Sabine</creator><creator>Felbor, Ute</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200502</creationdate><title>Non–heparan sulfate‐binding interactions of endostatin/collagen XVIII in murine development</title><author>Rychkova, Natalia ; Stahl, Sonja ; Gaetzner, Sabine ; Felbor, Ute</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3632-84390126bd584bf454a3572503f14cc8899eb72e25ce696509a6aa15205fdee43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Alkaline Phosphatase - metabolism</topic><topic>Animals</topic><topic>Binding Sites</topic><topic>Blotting, Western</topic><topic>Brain - embryology</topic><topic>Brain - metabolism</topic><topic>brain and eye development</topic><topic>Collagen - chemistry</topic><topic>Collagen Type XVIII - metabolism</topic><topic>collagen XVIII</topic><topic>Cornea - embryology</topic><topic>Electrophoresis, Polyacrylamide Gel</topic><topic>endostatin</topic><topic>Endostatins - metabolism</topic><topic>Eye - embryology</topic><topic>Gene Expression Regulation, Developmental</topic><topic>Genetic Vectors</topic><topic>heparan sulfate</topic><topic>Heparitin Sulfate - chemistry</topic><topic>Heparitin Sulfate - metabolism</topic><topic>Humans</topic><topic>In Situ Hybridization</topic><topic>Knobloch syndrome</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Phenotype</topic><topic>Protein Binding</topic><topic>Protein Structure, Tertiary</topic><topic>Recombinant Fusion Proteins - chemistry</topic><topic>Recombinant Fusion Proteins - metabolism</topic><topic>Time Factors</topic><topic>vascular endothelial growth factor</topic><topic>Vascular Endothelial Growth Factor A - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rychkova, Natalia</creatorcontrib><creatorcontrib>Stahl, Sonja</creatorcontrib><creatorcontrib>Gaetzner, Sabine</creatorcontrib><creatorcontrib>Felbor, Ute</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Developmental dynamics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rychkova, Natalia</au><au>Stahl, Sonja</au><au>Gaetzner, Sabine</au><au>Felbor, Ute</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Non–heparan sulfate‐binding interactions of endostatin/collagen XVIII in murine development</atitle><jtitle>Developmental dynamics</jtitle><addtitle>Dev Dyn</addtitle><date>2005-02</date><risdate>2005</risdate><volume>232</volume><issue>2</issue><spage>399</spage><epage>407</epage><pages>399-407</pages><issn>1058-8388</issn><eissn>1097-0177</eissn><abstract>Knobloch syndrome is characterized by a congenital generalized eye disease and cranial defect. Pathogenic mutations preferentially lead to a deletion or functional alteration of collagen XVIII's most C‐terminal endostatin domain. Endostatin can be released from collagen XVIII and is a potent inhibitor of angiogenesis and tumor growth. We show differential expression of binding partners for endostatin, vascular endothelial growth factor (VEGF), and the collagen XV endostatin homologue in murine embryonal development using a set of alkaline phosphatase fusion proteins. Consistent with the human phenotype, vascular mesenchyme in the developing eye was identified as endostatin's primary target. While endostatin predominantly bound to blood vessels, the VEGF164 affinity probe labeled nonvascular tissues such as forebrain, hindbrain, the optic nerve, and the surface ectoderm of the future cornea. Strikingly increased staining specificity was observed with a non–heparin/heparan sulfate‐binding endostatin probe. In contrast, elimination of the heparan sulfate binding site from VEGF led to complete loss of binding. The collagen XV endostatin homologue showed a highly restricted binding pattern. Oligomerization with endogenous endostatin was ruled out by use of collagen XVIII knockout mice. Our data provide strong evidence that collagen XVIII's C‐terminal endostatin domain harbors a prominent tissue‐binding site and that binding can occur in the absence of heparan sulfates in situ. Developmental Dynamics 232:399–407, 2005. © 2004 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>15614762</pmid><doi>10.1002/dvdy.20222</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1058-8388
ispartof Developmental dynamics, 2005-02, Vol.232 (2), p.399-407
issn 1058-8388
1097-0177
language eng
recordid cdi_proquest_miscellaneous_67366577
source Wiley-Blackwell Read & Publish Collection
subjects Alkaline Phosphatase - metabolism
Animals
Binding Sites
Blotting, Western
Brain - embryology
Brain - metabolism
brain and eye development
Collagen - chemistry
Collagen Type XVIII - metabolism
collagen XVIII
Cornea - embryology
Electrophoresis, Polyacrylamide Gel
endostatin
Endostatins - metabolism
Eye - embryology
Gene Expression Regulation, Developmental
Genetic Vectors
heparan sulfate
Heparitin Sulfate - chemistry
Heparitin Sulfate - metabolism
Humans
In Situ Hybridization
Knobloch syndrome
Mice
Mice, Knockout
Phenotype
Protein Binding
Protein Structure, Tertiary
Recombinant Fusion Proteins - chemistry
Recombinant Fusion Proteins - metabolism
Time Factors
vascular endothelial growth factor
Vascular Endothelial Growth Factor A - metabolism
title Non–heparan sulfate‐binding interactions of endostatin/collagen XVIII in murine development
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T14%3A48%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Non%E2%80%93heparan%20sulfate%E2%80%90binding%20interactions%20of%20endostatin/collagen%20XVIII%20in%20murine%20development&rft.jtitle=Developmental%20dynamics&rft.au=Rychkova,%20Natalia&rft.date=2005-02&rft.volume=232&rft.issue=2&rft.spage=399&rft.epage=407&rft.pages=399-407&rft.issn=1058-8388&rft.eissn=1097-0177&rft_id=info:doi/10.1002/dvdy.20222&rft_dat=%3Cproquest_cross%3E67366577%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3632-84390126bd584bf454a3572503f14cc8899eb72e25ce696509a6aa15205fdee43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67366577&rft_id=info:pmid/15614762&rfr_iscdi=true